MCS is understood as a physiological condition with measurable biological mechanisms—not a psychological disorder.
Your reactions are not imagined — they are measurable. In MCS, the body's chemical-sensing and immune systems become over-reactive, so tiny exposures set off an outsized alarm. Five mechanisms are under study: over-active mast cells, sensitized TRP nerve receptors (TRPV1/TRPA1) — the strongest of the five, and the only one tested by exposing a person and measuring the response — altered brain processing of odors, inherited differences in how the body processes chemicals (investigated, not established), and a genetic difference (HLA-DR) that the CIRS literature says lets certain biotoxins recirculate. These are interacting systems; which one starts the loop is the open question. The mechanism research is biological. Receptors, immune signalling and inherited susceptibility are what it investigates and what it measures.*
This page explains what happens in the body. For what starts MCS, see What causes MCS to begin? For the explanations you may have heard, such as detox, mast cells and mold, see The common explanations, checked.
This is where the research actually is. Neurobiological sensitization, immune dysregulation and genetic susceptibility are the mechanisms under investigation — measured in receptors, in blood, and on brain imaging.
Exposure to pollutants like PM2.5, VOCs, and fragrances can sensitize mast cells, leading to excessive inflammatory responses. MCS patients' mast cells may react to pollutants at concentrations as low as 50–75 ppm, compared to 100 ppm in unaffected individuals.
MCS is not mast cell disease. MCAS (mast cell activation syndrome) is its own condition, with lab tests and treatments that work. It overlaps with MCS, and some people have both. The overlap does not mean that MCAS causes most MCS, or that most people with MCS have MCAS. Mast cells are one candidate among several, not the explanation. If you have flushing, hives or sudden reactions that look allergic, ask to be tested. More: Mast cells, MCAS and MCS.
Transient receptor potential (TRP) channels, particularly TRPV1 and TRPA1, become hypersensitive in MCS patients, responding to low levels of VOCs and other chemicals. This is the strongest of the five, and the only one tested by provocation in living patients; receptor upregulation and sensitization are central to the 2021 mechanism review.[1] A 2024 critique in the same journal (Pitron et al.) argues the receptor reviews confused association with causation; the sensitization is measured, its causal role is not yet established.
Reacting is not the same as smelling. Your nose has two overlapping systems. One recognizes odors. The other detects chemical irritation through nerve endings in the nose, eyes, mouth and throat. The National Institutes of Health describes this second system as the “common chemical sense.” The two can be separated in testing. In Swedish studies, patients wearing a nose clip could not smell perfume and still developed cough and breathing symptoms, and exposing only their eyes did the same (Millqvist 1996, PMID: 8837670; Millqvist 1999, PMID: 10380782). In a blinded study, people with chemical intolerance felt more irritation than others from a low dose of an irritant hidden under another odor (Claeson 2017, PMID: 28359837). So a scent you tolerate can dominate what you smell while the original chemical still reaches those nerve endings, and your airways.
The nerve endings in your nose, eyes, throat, airways and skin carry tiny gates called TRP channels. TRPA1 opens in response to reactive chemicals such as formaldehyde, chlorine, smoke and many fragrance ingredients. TRPV1 opens in response to heat, acid and capsaicin, the hot part of chili peppers. When a gate opens, the nerve fires and sends a warning signal toward the brain.
“Sensitized” means two things change. Each gate opens at a lower trigger level, and the nerve ending can carry more gates than before. The same tiny exposure that a healthy nerve ignores now produces a strong signal.
The signal does not only travel to the brain. When these nerves fire, they also release inflammatory messengers, called substance P and CGRP, right where the exposure happened. Those messengers swell nearby tissue, irritate the airways, and can set off nearby mast cells without any allergy antibody involved. The mast cells then release their own chemicals, and some of those make the TRP gates even easier to open the next time. That loop is called neurogenic inflammation. It helps explain how one small exposure can turn into a reaction that lasts for days. The loop is well measured in tissue and animal studies; it has not been proven to be what starts MCS.
There is a second layer. Studies that applied capsaicin to the skin of people with MCS found the extra pain spread over a wider area than in healthy people. That points to the nervous system turning up the volume on incoming signals, not just the nerve endings.
This is also why no blood or urine test can explain a reaction. The reaction lives in how sensitive the gates have become, not in how much chemical is in your body. More detail: TRPV1 and TRPA1 in MCS and What testing can and can’t tell you.
Nothing has been shown to switch sensitized receptors back to normal. But several things may lower how often and how hard they are triggered, and that is what most people need day to day.
Avoidance. Every exposure fires the sensitized nerves, and every firing releases messengers that keep them sensitized. Fewer exposures break that loop and give the nerve endings and mast cells a chance to quiet down. This is the best-supported step anyone with MCS can take: in a survey of 917 people with self-reported MCS, about 95 percent of those who had tried avoiding chemicals rated it helpful. See Does avoiding chemicals help MCS?.
Vitamin C. It may help in two ways. It helps the body lower histamine, one of the main chemicals mast cells release, and it is a strong antioxidant. Oxidative stress, a kind of chemical wear on cells, is one of the known things that opens TRPA1 gates, so lowering it is a reasonable way vitamin C could help.
Magnesium. It helps keep nerve cells from over-firing, including at the brain receptors involved in the nervous system’s “stuck on alarm” state, and it plays a part in keeping mast cells calm. Low magnesium makes nerves more excitable.
Vitamin D. Mast cells and immune cells carry vitamin D receptors, and low vitamin D is linked to more inflammatory and allergic reactivity. People with MCS are often low because they avoid going out, and inflammation may use it up faster.
These nutrient effects are supported by laboratory and medical research, but none has been tested in a trial of people with MCS. Many people with MCS report that they help, and they are reasonable to try with your clinician. See Supplements & MCS for which forms are best tolerated and how to introduce them safely.
Stress. Everyday stress may matter too. Stress hormones can set off mast cells directly, and the brain can turn incoming nerve signals up or down. See the question on stress below.
Functional brain imaging shows that MCS patients process odors differently, with heightened activity in sensory and limbic regions. Studies using SPECT scans and fMRI have identified specific patterns of neuroinflammation, particularly affecting the hippocampus, amygdala, and prefrontal cortex.[2]
Genetic studies point to inherited differences in how people process chemicals, but not in the direction the “toxic load” story assumed. The best-known finding, from Toronto in 2004, linked MCS to the active and rapid variants of two metabolic genes (CYP2D6 and NAT2) — faster metabolism, not slower — and it has not been consistently replicated. Reduced glutathione is a measured state in some cohorts, not a genotype and not a proven cause. Susceptibility is real; no gene causes MCS, and no test diagnoses it. Gene variants and MCS →
Within the CIRS clinical literature, certain HLA-DR gene variants are associated with an impaired ability of the immune system to recognize and tag specific biotoxins for clearance — a mechanism proposed by that literature, not independently confirmed by mainstream immunology. This is distinct from liver enzyme deficiencies — the detoxification machinery works, but proponents argue the immune system does not signal it to clear biotoxin targets. For these individuals, mold exposure can trigger indefinite biotoxin recirculation and chronic inflammation (CIRS). HLA-DR genotyping is a one-time blood test that identifies these variants. Learn more about HLA genetics →
For the full body of evidence and citations, see the Research Library → — this page explains the mechanisms; the library holds the studies. Is the science actually settled? See Is MCS psychological or physical? →
For some people the sensitivity reaches past chemicals to sound, light and touch. What has been measured, and what has not: Sensory overload and MCS →
Not so far. No drug, supplement or program has been shown to reset sensitized TRP receptors back to normal in people with MCS. Drugs that block TRPV1 were tested for pain, but they disturbed body temperature control and none reached the market. A high-dose capsaicin skin patch is approved for some nerve pain and works by temporarily switching off pain nerve endings in one patch of skin; it has not been studied in MCS and cannot be used on the airways. What can help is lowering how often and how hard the receptors are triggered: reducing exposures, calming mast cells, and supporting the body with the nutrients described above.
It is a real proposal from a real researcher, Martin Pall, and some of its parts have been measured, but the cycle itself has never been tested in people with MCS. The theory says nitric oxide and a related damaging molecule, peroxynitrite, feed each other in a self-sustaining loop that keeps the body sensitive. Raised nitric oxide markers and oxidative stress have been found in some MCS studies, which keeps the idea alive. But no study has shown the loop runs in MCS patients, and treatment plans built on it have not been tested in trials. It should not be treated as the explanation for MCS. The best-supported picture remains sensitized TRP receptors, mast cells, and a nervous system stuck on high alert. More: Oxidative stress, glutathione and metabolism in MCS.
It is a useful clue about which part of MCS is active for you. Vitamin C lowers histamine and fights oxidative stress. If it clearly helps, especially on your worst days, histamine and mast cells, oxidative stress, or both are likely part of your picture. That fits MCS; it does not point to a different illness. It may also be a good reason to ask your doctor about mast cell testing, starting with a tryptase blood test. See MCS Testing.
Possibly. People with MCS are often low in vitamin D, because they avoid going outside and because ongoing inflammation may use it up faster, so many need more than the average person to reach a good level. The right amount depends on your blood level. Ask for a 25-OH vitamin D test, bring your level solidly into range with your clinician, and retest after about three months. Some practitioners aim for a higher range than mainstream guidelines; that has not been proven better for MCS, but keeping a deficiency from coming back clearly matters.
It may. Magnesium naturally blocks a brain receptor (the NMDA receptor) that plays a central part in the nervous system becoming over-sensitive, and it steadies nerve and mast cell activity. Low magnesium makes nerves more excitable. It has not been tested in an MCS trial, but it is low-risk in the right form and widely reported as helpful. See Supplements & MCS for the best-tolerated forms.
Stress can likely make reactions worse, and calming it may help, through real body pathways. Stress hormones, especially one called CRH, can set off mast cells directly, and mast cell chemicals make TRP receptors easier to trigger. In animal studies, stress makes these receptors more reactive. The brain also turns incoming nerve signals up or down, and stress turns the volume up. Emotional stress adds to oxidative stress as well. No study has measured TRP sensitivity in people with MCS before and after stress reduction, so this is well-founded but not proven. None of this means MCS is “in your head.” It means the body’s alarm system responds to stress the way it responds to everything else. Better sleep, gentle breathing practices and anything that lowers your daily stress load are reasonable additions to exposure reduction, never a replacement for it. More: Can calming the nervous system still help? and Limbic Retraining & MCS.
* These five are not equals. Receptor sensitization is first, because it is the only one that has been tested by provocation in a living patient — the exposure is applied and the response is measured rather than reported. The other four are real lines of investigation with real findings behind them, and none of them has been tested that way. No mechanism here is established as the cause.
No. The AMA has issued nothing on MCS this century; its cited documents are from 1992 and 2000 and address clinical ecol…
MCS is a chronic, physiological condition in which everyday low-level chemical exposures produce real reactions. The def…
Why is MCS so confusing? Different triggers, thresholds, and reactions per person; hills and valleys; and why "this cure…
The by-system symptom list for MCS: neurological, respiratory, fatigue, gastrointestinal, cardiovascular and sensory. Ho…
Learn about TILT — Toxicant-Induced Loss of Tolerance — the two-stage mechanism behind Multiple Chemical Sensitivity…
EHS symptoms are real and overlap heavily with MCS. Whether electromagnetic fields cause them is not established; blinde…
Fibromyalgia and MCS overlap in some samples and both involve altered sensory processing. Not the same disease; a shared…
EDS is genetic; chemicals do not cause it. But EDS and mast cell activation syndrome often co-occur, and MCAS is a docum…
MCS and ME/CFS overlap in fatigue, cognition, sensory intolerance and autonomic symptoms. Real overlap, not one disease;…
Some people with MCS find sound, light or touch overwhelming. Sound tolerance has been measured in MCS; light and touch …
Detox, mast cells, mold, genes, the vagus nerve: each common explanation for MCS, with what is true in it, what has not …
Chronic metal exposure can look like MCS symptom for symptom. Measure metal burden with standard tests when warranted; c…
Free TILT Self-Assessment including the BREESI screener and QEESI — the gold standard for identifying chemical intoler…
Damp buildings harm respiratory health on established evidence. The CIRS biotoxin model is one group’s proposal, not i…
The CIRS model of mold biotoxins — HLA-DR variants, recirculation, low MSH, MARCoNS — stated as its originating grou…
CDC found 449 invasive mold disease cases with 45% 90-day mortality. Serious, but not evidence that household mold or MC…
The current state of MCS research: what the 2023 Molot review changed, TRP modulation, biotoxin elimination, neuroplasti…
Is MCS psychological or physical? The measurements point physical: receptor studies, skin biopsy, imaging, genetics, and…
The documented history of MCS: from Theron Randolph's 1950s observations through the 1999 consensus criteria, WHO recogn…
The peer-reviewed research on chemical exposure, MCS, indoor air and human health, including the strongest contrary evid…